Investors / filer profile

Frost Phillip MD Et Al

active in 3 companies · 1 of 2 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 48
Filings: 3
Companies: 2026-08-03
Last filed

EDGAR · CIK 0000898860 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+18.1%

median move per position

+9.8%

S&P 500 median, same spans

1 of 2

beat the S&P ~6mo later

1 position still inside the ~6-month window — not scored yet.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$4.37M bought

All filings on record

Every Form 4 transaction we track for this filer


COCPCocrystal Pharma, Inc.	Buy $70.6K · 75,000 sh	2026-08-03	—
COCPCocrystal Pharma, Inc.	Buy $20.0K · 20,000 sh	2026-02-24	—
COCPCocrystal Pharma, Inc.	Buy $47.3K · 50,000 sh	2026-02-06	—
COCPCocrystal Pharma, Inc.	Buy $47.3K · 50,000 sh	2025-12-31	—
COCPCocrystal Pharma, Inc.	Buy $19.3K · 20,000 sh	2025-12-30	—
COCPCocrystal Pharma, Inc.	Buy $38.9K · 40,000 sh	2025-12-26	—
COCPCocrystal Pharma, Inc.	Buy $24.3K · 25,000 sh	2025-12-24	—
COCPCocrystal Pharma, Inc.	Buy $2.5K · 2,500 sh	2025-11-26	—
COCPCocrystal Pharma, Inc.	Buy $1.5K · 1,500 sh	2025-11-26	—
COCPCocrystal Pharma, Inc.	Buy $18.8K · 20,000 sh	2025-11-25	—

COCPBuy

2026-08-03 · Cocrystal Pharma, Inc.

$70.6K

—

COCPBuy

2026-02-24 · Cocrystal Pharma, Inc.

$20.0K

—

COCPBuy

2026-02-06 · Cocrystal Pharma, Inc.

$47.3K

—

COCPBuy

2025-12-31 · Cocrystal Pharma, Inc.

$47.3K

—

COCPBuy

2025-12-30 · Cocrystal Pharma, Inc.

$19.3K

—

COCPBuy

2025-12-26 · Cocrystal Pharma, Inc.

$38.9K

—

COCPBuy

2025-12-24 · Cocrystal Pharma, Inc.

$24.3K

—

COCPBuy

2025-11-26 · Cocrystal Pharma, Inc.

$2.5K

—

COCPBuy

2025-11-26 · Cocrystal Pharma, Inc.

$1.5K

—

COCPBuy

2025-11-25 · Cocrystal Pharma, Inc.

$18.8K

—

Newest 10 of 48 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.